The Jerusalem Post - Israel News

Merck

New Collaboration to validate CRISPR Genome-editing tools in plants

Merck KGaA signs collaboration and license agreement with Israeli company BetterSeeds to accelerate use of CRISPR in agricultural applications, making it more widely available.

|ByJERUSALEM POST STAFF
BetterSeeds CEO, Ido Margalit
An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters on October 26, 2021.

Cheap version of Merck COVID pill to be made for poorer nations

The antiviral drug, which received emergency approval in the United States in December, reduces hospitalizations and deaths of high-risk patients by around 30%, according to clinical trial results.

|ByREUTERS
DR. ELIAV BARR, senior vice president and head of global medical affairs at Merck Research Laboratories in Pennsylvania.

The toxic brew of politics and COVID-19

HEALTH AFFAIRS: Merck’s senior VP, Dr. Eliav Barr, tells the ‘Post’ about the challenge of public compliance and what’s next for the international pandemic.

|ByMAAYAN JAFFE-HOFFMAN
An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters on October 26, 2021.

Merck's COVID-19 pill to arrive in Israel within two weeks

Molnupiravir received Emergency Use Authorization on Thursday evening in Israel. It is used to treat mild to moderate coronavirus in adults.

|ByMAAYAN JAFFE-HOFFMAN

Britain approves Merck's COVID-19 pill

The green light is the first for an oral treatment for COVID-19 and the first for a COVID-19 drug that will be administered widely in the community.

NOVEMBER 5, 2021ByREUTERS
An experimental COVID-19 treatment pill called molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021.

The world is fighting for COVID treatments, here’s how Israel is helping

Israel has played – and continues to play – a significant role in the fight for a cure for corona.

OCTOBER 27, 2021ByMAAYAN JAFFE-HOFFMAN
An experimental COVID-19 treatment pill called molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021.

Pfizer, AstraZeneca help launch 'computational science' lab in Israel

A partnership between six leading tech and pharma companies wants to create and adopt new AI technologies that could transform the process of drug discovery and development.

OCTOBER 19, 2021ByMAAYAN JAFFE-HOFFMAN
ISRAELI BIOTECH start-up Atox Bio is developing a drug that it hopes will treat those suffering from flesheating bacteria.

Merck seeks first US authorization for COVID-19 tablet

An authorization from the US Food and Drug Administration could help change clinical management of COVID-19 as the pill can be taken at home.

OCTOBER 11, 2021ByREUTERS
The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, US, July 12, 2018.

Merck says deal signed with Singapore on COVID-19 antiviral pill

Though Singapore's health ministry did not immediately confirm the deal, it would be the fourth country to enter talks of purchase with Merck.

OCTOBER 6, 2021ByREUTERS
An experimental COVID-19 treatment pill called molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021.